We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$35.5B
AUM Growth
+$586M
(+1.7%)
Cap. Flow
-$946M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
25.54%
Holding
2,317
New
189
Increased
687
Reduced
1,108
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
British American Tobacco
BTI
|
+$104M |
| 2 |
Occidental Petroleum
OXY
|
+$86.7M |
| 3 |
Canadian Imperial Bank of Commerce
CM
|
+$82.9M |
| 4 |
Public Storage
PSA
|
+$71.4M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$418M |
| 2 |
Consolidated Edison
ED
|
+$212M |
| 3 |
Crown Castle
CCI
|
+$103M |
| 4 |
Target
TGT
|
+$93.8M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 14.38% |
| 2 | Healthcare | 14.1% |
| 3 | Communication Services | 10.76% |
| 4 | Technology | 10.06% |
| 5 | Utilities | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIOX
1776
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $20K | ﹤0.01% |
+474
| New | +$21.3K |
|
|
WAC
1777
DELISTED
Walter Investment Mgt Corp
WAC
| $20K | ﹤0.01% |
23,680
-6,173
| -21% | -$3.32K |
|
1778
RadNet
RDNT
$6.07B
| $19K | ﹤0.01% |
1,832
-40
| -2% | -$417 |
|
1779
Shore Bancshares
SHBI
$787M
| $19K | ﹤0.01% |
1,146
| – | – |
|
1780
WD-40
WDFC
$2.55B
| $19K | ﹤0.01% |
158
-4
| -2% | -$459 |
|
1781
Metallus
MTUS
$793M
| $19K | ﹤0.01% |
1,246
-441
| -26% | -$6.71K |
|
|
VRS
1782
DELISTED
Verso Corporation
VRS
| $19K | ﹤0.01% |
+1,058
| New | +$10.1K |
|
|
CETV
1783
DELISTED
Central European Media Enterprises Ltd
CETV
| $19K | ﹤0.01% |
4,123
+1,022
| +33% | +$4.69K |
|
|
APTI
1784
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $19K | ﹤0.01% |
+796
| New | +$16.9K |
|
1785
Atkore
ATKR
$3.19B
| $18K | ﹤0.01% |
843
+366
| +77% | +$7.35K |
|
1786
Cavco Industries
CVCO
$4.12B
| $18K | ﹤0.01% |
118
-1
| -0.8% | -$150 |
|
1787
FS Bancorp
FSBW
$350M
| $18K | ﹤0.01% |
668
+132
| +25% | +$3.63K |
|
1788
SFL Corp
SFL
$1.84B
| $18K | ﹤0.01% |
1,148
+852
| +288% | +$12.8K |
|
|
CONN
1789
DELISTED
Conn's Inc.
CONN
| $18K | ﹤0.01% |
512
+73
| +17% | +$2.23K |
|
|
VSI
1790
DELISTED
Vitamin Shoppe Inc.
VSI
| $18K | ﹤0.01% |
4,059
| – | – |
|
|
RPXC
1791
DELISTED
RPX Corporation
RPXC
| $18K | ﹤0.01% |
1,336
-36
| -3% | -$476 |
|
|
KEM
1792
DELISTED
KEMET Corporation
KEM
| $18K | ﹤0.01% |
1,189
-76,417
| -98% | -$1.46M |
|
1793
Cytokinetics
CYTK
$9.64B
| $17K | ﹤0.01% |
2,063
+1,580
| +327% | +$17.9K |
|
1794
Gaming and Leisure Properties
GLPI
$11.8B
| $17K | ﹤0.01% |
464
| – | – |
|
1795
Lennar Class B
LEN.B
$18.9B
| $17K | ﹤0.01% |
+346
| New | +$16K |
|
1796
Primoris Services
PRIM
$4.13B
| $17K | ﹤0.01% |
624
-16
| -3% | -$445 |
|
1797
PTC Therapeutics
PTCT
$5.48B
| $17K | ﹤0.01% |
1,005
-1,546
| -61% | -$26.2K |
|
|
HTO
1798
H2O America
HTO
$2.61B
| $17K | ﹤0.01% |
273
-1,052
| -79% | -$66.6K |
|
1799
The Bancorp
TBBK
$2.04B
| $17K | ﹤0.01% |
1,743
+797
| +84% | +$7.31K |
|
|
XHR
1800
Xenia Hotels & Resorts
XHR
$1.61B
| $17K | ﹤0.01% |
810
-22
| -3% | -$479 |
|
Similar funds
Federated Hermes's Q4 2017 Portfolio in Review
As of Q4 2017, Federated Hermes held 2,317 positions worth $35.5B, up 1.7% from $34.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Federated Hermes's Q4 2017 filing shows 189 new, 687 increased, 1,108 reduced and 152 closed positions. Its largest new stake was Azul: 1,190,200 shares worth $28.4M. The largest sale was AbbVie, an estimated $418M.
By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.
- Federated Hermes's largest Q4 2017 buy was Azul: 1,190,200 shares worth $28.4M.
- Federated Hermes added most to British American Tobacco in Q4 2017, an estimated $104M increase.
- Federated Hermes's biggest Q4 2017 reduction was AbbVie, cutting an estimated $418M.
- Federated Hermes fully exited iShares Biotechnology ETF in Q4 2017, selling an estimated $36.1M.
- Federated Hermes's ten largest holdings make up 26% of its $35.5B portfolio in Q4 2017.
- Federated Hermes opened 189 new positions and closed 152 in Q4 2017.
- Federated Hermes's portfolio value rose 1.7% quarter-over-quarter to $35.5B.
Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.